Finerenone is the first therapy targeting the mineralocorticoid receptor pathway to demonstrate cardiovascular benefits in heart failure patients
NUFYMCO BLA has been approved by the USFDA
UK headquartered digital health scale-up strengthens global tech and innovation footprint in the country
The additional production will raise the installed capacity by 400 million and available capacity by 240 million at the facility
The company along with its subsidiaries has overall bed capacity of 8800+ beds as on 30th September, 2025
The initiative is focused on a problem that continues to plague cancer outcomes in India
The study is being conducted under a USFDA IND, has received U.S. Fast Track Designation for SLE-ITP, and has obtained IND approval from China’s Center for Drug Evaluation
The expansion includes a larger technical and service team and increased local procurement
The funding will support the pivotal Phase 3 clinical trial of neridronate in CRPS-1
The new facility is expected to generate 500-600 new jobs in the region
Subscribe To Our Newsletter & Stay Updated
